Deltec Asset Management’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History

Deltec Asset Management’s Portfolio KNTE Stock Details KNTE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,039,800	Closed	-$2.77M	–	175
2024 Q1	$2.77M	Buy	+1,039,800	New	+$2.57M	0.55%	44

Deltec Asset Management's KNTE Position: Q2 2024 in Review

Deltec Asset Management sold out of Kinnate Biopharma Inc. Common Stock (KNTE) in Q2 2024, closing a stake of 1,039,800 shares — an estimated $2.77M sold.

Deltec Asset Management first reported a position in KNTE in Q1 2024 and held it in 1 quarter. The position peaked at $2.77M in Q1 2024. 0 funds tracked by Wall St. Rank hold KNTE as of Q2 2024.

Deltec Asset Management reported no remaining Kinnate Biopharma Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Deltec Asset Management sold 1,039,800 Kinnate Biopharma Inc. Common Stock shares in Q2 2024, an estimated $2.77M.
Deltec Asset Management first reported a position in Kinnate Biopharma Inc. Common Stock in Q1 2024 and held it in 1 quarter.
Deltec Asset Management's Kinnate Biopharma Inc. Common Stock position peaked at $2.77M in Q1 2024.
0 funds tracked by Wall St. Rank held Kinnate Biopharma Inc. Common Stock as of Q2 2024.

Based on Deltec Asset Management's 13F filing for Q2 2024, filed 16 Jul 2024.